We have characterized the genetic landscape of CAA in AD cases, providing evidence of additional genetic contribution to variability of this phenotype beyond APOE. We identified a novel CAA locus, LINC-PINT and a splice variant that attenuates CAA levels in AD patients lacking APOEε4. This evidence concerns the gene LINC-PINT and Alzheimer disease.